AltMountain

Aquamarine Financial (cayman) LTD

Grand Cayman, Cayman Islands · CRD 335337
Hedge fund manager

Aquamarine Financial (cayman) LTD is an SEC-registered investment adviser based in Grand Cayman, Cayman Islands that reports managing 1 hedge fund on Form ADV. It reports $5.8 billion in regulatory assets under management. Its private funds, of all types, hold $2.0 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +9.2% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +34.3% from Q4 2025 to Q2 2026, compared with +12.1% for the S&P 500, based on 13F filings.

Regulatory assets under management
$5.8 billionForm ADV Item 5.F
Gross assets of private funds
$2.0 billionAll private fund types, Form ADV
Hedge funds managed
11 private funds in total
Employees
5Form ADV Item 5.A
Registration
SEC-registered adviserCRD 335337
Latest Form ADV
09/11/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.

Estimated from 13F · 2026 YTD+9.2%Through Q2 2026 · S&P 500 +9.5%
Estimated from 13F · 3 quarters+34.3%Q4 2025 – Q2 2026
S&P 500+12.1%Same quarters, price only
13F holdings$1.8 billion17 positions, 2026-06-30
$98$117$136Q4 2025Q1 2026Q2 202613F est. $134S&P 500 $112
QuarterEst. 13F returnS&P 500
Q2 2026-1.1%+14.8%
Q1 2026+10.5%-4.6%
Q4 2025+23.0%+2.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.

13F holdings as of Sep 30, 2026

All 16 share positions ($1,943,652,286) reported by Aquamarine Financial (Cayman) Ltd on Form 13F for the quarter ended Sep 30, 2026, filed Nov 13, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.

Share of the reported 13F portfolio, ten largest positions

  • Banco Bradesco S A41.07%
  • YPF Sociedad Anonima33.52%
  • Ondas Inc7.59%
  • Grupo Financiero Galicia S.A6.55%
  • Petroleo Brasileiro S A3.52%
  • Banco Macro S A2.87%
  • Pagaya Technologies LTD1.53%
  • Banco Bbva Argentina S A1.12%
  • American Superconductor Corp0.79%
  • Oramed Pharmaceuticals Inc0.64%
StockValue% of 13F portfolioSharesShares vs prior quarter
Banco Bradesco S A$798,233,01141.07%226,718,134+21.27%
YPF Sociedad Anonima$651,531,99033.52%12,996,848+4.43%
Ondas Inc$147,526,3737.59%20,126,381New
Grupo Financiero Galicia S.A$127,266,2366.55%3,417,079-2.80%
Petroleo Brasileiro S A$68,322,1203.52%3,260,000New
Banco Macro S A$55,809,9152.87%833,855-1.02%
Pagaya Technologies LTD$29,767,1911.53%1,718,660-2.97%
Banco Bbva Argentina S A$21,730,0701.12%1,691,056-0.59%
American Superconductor Corp$15,412,2600.79%529,449New
Oramed Pharmaceuticals Inc$12,392,1580.64%2,653,567+5.63%
Alpha Tau Medical LTD$10,757,5800.55%721,501Unchanged
Innoviz Technologies LTD$2,924,1850.15%8,051,171-7.92%
Pulsenmore LTD$790,1930.04%338,541Unchanged
Transportadora De Gas Del Su$770,6110.04%29,696Unchanged
Central Puerto S A$233,8930.01%19,314Unchanged
Alto Ingredients Inc$184,5000.01%50,000New

Changes since Jun 30, 2026

Comparing the share counts in the two quarter-end filings: 4 new positions, 5 sold out, 3 increased, 5 reduced and 4 unchanged.

Number of positions (a count, not dollars)

  • New positions4
  • Increased3
  • Unchanged4
  • Reduced5
  • Sold out5

New positions

StockValueShares
Ondas Inc$147,526,37320,126,381
Petroleo Brasileiro S A$68,322,1203,260,000
American Superconductor Corp$15,412,260529,449
Alto Ingredients Inc$184,50050,000

Sold out

StockValue at Jun 30, 2026Shares held then
Nu Hldgs LTD$119,941,2178,977,636
Gerdau SA$67,573,73116,726,171
Banco Santander Brasil S A$54,569,46610,394,184
Cosan S A$6,039,0842,096,904
Valens Semiconductor LTD$15,670559,653

Largest increases

StockChange in sharesChangeValue nowShares now
Banco Bradesco S A+39,770,000+21.27%$798,233,011226,718,134
YPF Sociedad Anonima+551,900+4.43%$651,531,99012,996,848
Oramed Pharmaceuticals Inc+141,392+5.63%$12,392,1582,653,567

Largest reductions

StockChange in sharesChangeValue nowShares now
Grupo Financiero Galicia S.A-98,485-2.80%$127,266,2363,417,079
Pagaya Technologies LTD-52,549-2.97%$29,767,1911,718,660
Banco Macro S A-8,635-1.02%$55,809,915833,855
Innoviz Technologies LTD-692,252-7.92%$2,924,1858,051,171
Banco Bbva Argentina S A-10,022-0.59%$21,730,0701,691,056

Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.

From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures

Large ownership stakes (Schedule 13D and 13G)

CompanyFilingPercent of classSharesFiledSource
Oramed Pharmaceuticals Inc.13G amendment6.38%2,653,567Nov 13, 2026SEC.gov ↗
Pulsenmore LTD.13G5.02%338,541Oct 8, 2026SEC.gov ↗

A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Oct 8, 2026, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.

Hedge funds filing Form D (1)

Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​​⁠